Caring Brands Enters Exclusive License Agreement with Itonis
Caring Brands entered into an exclusive worldwide license agreement with Itonis Inc. to manufacture, market, and distribute Emesyl, Itonis's over-the-counter nausea relief product. The agreement provides Caring Brands with full rights to commercialize Emesyl and to oversee all manufacturing activities associated with the product. Under the terms of the agreement, Caring Brands will assume responsibility for product manufacturing, marketing, sales strategy, and global distribution. Itonis will provide technical information, product formulation data, historical sales information, and intellectual property details to support Caring Brands' commercial launch and ongoing development efforts. The agreement includes a royalty structure based on future net sales, along with the potential for Caring Brands to earn equity in Itonis tied to revenue milestones. Caring Brands expects to provide further updates on product timelines, manufacturing progress, and commercial rollout as these initiatives advance.
Trade with 70% Backtested Accuracy
Analyst Views on CABR
About CABR
About the author

- Investigation Launched: The Schall Law Firm has announced an investigation into Caring Brands Inc. to determine if the company issued false or misleading statements, which could impact investor rights and indicate potential misconduct in information disclosure.
- Investor Rights Protection: The investigation aims to protect shareholders who have suffered losses, encouraging affected investors to contact the law firm, highlighting the legal risks the company faces that may negatively affect its stock price.
- Legal Expertise: Schall Law Firm specializes in securities class action lawsuits and shareholder rights litigation, indicating its extensive experience in handling such cases, which may provide strong legal support for investors.
- Potential Consequences: Should the investigation confirm violations by Caring Brands, the company could face legal liabilities and financial losses, thereby affecting its market reputation and future growth prospects.






